Navigation Links
Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology
Date:5/20/2013

ATLANTA, May 20, 2013 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company that has developed and is commercializing a unique technology to deter prescription drug abuse today announced that its founder and President, Anthony Soscia , has been chosen as a finalist for the Atlanta Business Chronicle's Health-Care Heroes Awards. The awards are presented annually by the Atlanta Business Chronicle to honor individuals and organizations demonstrating excellence and deserving recognition in the health-care community. From the doctors finding cures for deadly diseases to organizations serving our community's health care needs and allied professionals making a difference in the lives of many.

Atlantic's patented abuse deterrent platform has been designed to resist attempts to easily extract a drug from an oral dosage form and may sequester and reduce drug release of a pharmaceutical that has been subjected to a variety of physical methods of tampering and abuse. The technology can be applied to immediate as well as sustained release drug candidates such as oxycodone. "We believe SMART/Script™ is a unique technology that may have a significant impact on prescription drug abuse and misuse and are honored by the Health Care Heroes recognition," said Anthony Soscia , President of Atlantic Pharmaceuticals.

About SMART/Script™

SMART/Script™ (SMART, Simple, controllable, resistant, insoluble, physical trap) a novel, patented drug delivery technology, was designed to prevent easy drug extraction and to deter the abuse of medications via known routes of abuse or misuse, including chewing, snorting, and injecting. Orally delivered prescription pharmaceuticals, such as narcotics, are frequently subjected to abuse and misuse via chewing and swallowing or crushing and either snorting or injecting the resultant powder in order to obtain a fast euphoria.  A product formulated with SMART/Script™, however, resists extraction in water or alcohol and can be used with a broad range of opioids and non-opioids in immediate or extended release forms. SMART/Script™ is also unique among competitive technologies in that physical manipulation, such as chewing or crushing, may result in reducing the release of the drug as opposed to increasing it.

About Atlantic Pharmaceuticals, Inc.

Atlantic Pharmaceuticals is a specialty pharmaceutical company using its patented technology to produce novel therapeutics that resist attempts at tampering and may be useful to reduce abuse of certain prescription drugs. Based on the Company's proprietary technology, SMART/Script™, Atlantic is developing a pipeline of abuse-deterrent products that are nearing pivotal testing.

The Health-Care Heroes Award winners were revealed at the 16th annual award presentation dinner on May 16 at the Cobb Energy Centre.

Please visit atlanticpharma.com for more information.

Contact: Anthony Soscia , President 
Email
404-994-5135

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

 


'/>"/>
SOURCE Atlantic Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
2. Aveo Pharmaceuticals, Inc. Sued by Investor
3. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
4. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
5. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
6. Access Pharmaceuticals Reports First Quarter Results
7. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
8. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
9. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
10. Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference
11. Savient Pharmaceuticals Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/9/2017)... 8, 2017 ... Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, September 18 th .The ... free MRI brain scans to the public.Where:  BTF,s ... at 501 K Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the ...
(Date:9/7/2017)... , Sept. 7, 2017  Eli Lilly and ... actions to streamline operations to more efficiently focus ... its cost structure. Global workforce reductions, including those ... expected to impact approximately 3,500 positions. ... expects annualized savings of approximately $500 million that ...
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir ... Smart Spirometer, announced today a partnership with Novartis Pharma AG ... solidifies NuvoAir,s position as the leading mobile spirometry platform and ... patients. ... test ...
Breaking Medicine Technology:
(Date:9/26/2017)... , ... September 26, 2017 , ... “Sonflower Submission”: ... strong-willed nature to the inevitable destinations of negativity, complaining and the need to always ... to take effect in order for a lesson in stress-less living to be learned. ...
(Date:9/26/2017)... ... September 26, 2017 , ... “The Great Creator Saves Boobie and Ceebie”: a tool families ... Boobie and Ceebie” is the creation of published author, G.S. White, a devoted follower of ... in New Jersey. , “This book is not only for children but also to ...
(Date:9/25/2017)... ... September 25, 2017 , ... SignatureCare Emergency Center ... $1000 student scholarship is awarded each semester to a deserving student. Congratulations Ashlea! ... is a medical student at Arizona State University with a 3.63 GPA. Grabau ...
(Date:9/25/2017)... ... ... The Renal Support Network (RSN) is proud to announce the launch of ... focused on RSN’s mission to empower people who have kidney disease to become knowledgeable ... Our unique website is loaded with hundreds of exclusive personal stories. These posts are ...
(Date:9/25/2017)... ... 25, 2017 , ... FDAnews Expert Insight Series:, Device Regulation ... – 3:00 p.m. ET, http://www.fdanews.com/deviceregulation      , FDA Commissioner Scott ... short months:, ,     The first device recall over cybersecurity (a ...
Breaking Medicine News(10 mins):